TSE:ACBAurora Cannabis Stock Price, Forecast & News

Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ACB stock has increased by 1,295.7% and is now trading at C$16.33. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc (TSE:ACB) issued its quarterly earnings results on Thursday, May, 14th. The company reported ($0.99) earnings per share for the quarter, missing analysts' consensus estimates of ($0.70) by $0.29. The business earned $75.52 million during the quarter, compared to analysts' expectations of $63.44 million. View Aurora Cannabis' earnings history.

10 analysts have issued 12 month price targets for Aurora Cannabis' stock. Their forecasts range from C$2.00 to C$24.00. On average, they expect Aurora Cannabis' stock price to reach C$13.42 in the next year. This suggests that the stock has a possible downside of 17.8%. View analysts' price targets for Aurora Cannabis.

News articles about ACB stock have been trending neutral recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aurora Cannabis earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Aurora Cannabis.

Some companies that are related to Aurora Cannabis include Hikma Pharmaceuticals (HIK), Evotec (EVT), Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), Hexo (HEXO), OrganiGram (OGI), HEXO (HEXO), Next Science (NXS), Amryt Pharma (AMYT), ICC Labs (ICC), Benchmark (BMK), Green Organic Dutchman (TGOD) and ESSA Pharma (EPI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), OrganiGram (OGI), Cronos Group (CRON), Green Organic Dutchman (TGOD), Micron Technology (MU), Alibaba Group (BABA) and Advanced Micro Devices (AMD).

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

One share of ACB stock can currently be purchased for approximately C$16.33.

Aurora Cannabis has a market capitalization of C$1.84 billion and generates C$305.73 million in revenue each year. Aurora Cannabis employs 967 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.